Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 3 | Genome Medicine

Figure 3

From: The emergence of commercial genomics: analysis of the rise of a biotechnology subsector during the Human Genome Project, 1990 to 2004

Figure 3

Financial trends of top 15 public genomics firms. Top 15 genomics firms by market capitalization are: Applera, Millennium Pharmaceuticals, Invitrogen, OSI Pharmaceuticals, Gen-Probe, Affymetrix, Protein Design Labs, Human Genome Sciences, ZymoGenetics, Abgenix, Incyte, Digene, Exelixis Pharmaceuticals, Lexicon Genetics, and Rigel Pharmaceuticals. PPE, plant, property and equipment; R&D Exp, research and development expenditures; Total Exp, total expenditures.

Back to article page